Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Myocardial Oedema in Acute Myocardial Infarction (AMI)
A clinical trial investigating myocardial oedema in patients with acute myocardial infarction has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium. [Phase 3]
Phase 3 IMMEDIATE trial evaluating out-of-hospital glucose-insulin-potassium therapy for acute cardiovascular conditions has completed; resu…
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Bone Marrow-Derived Stem Cell Transfer in Acute Myocardial Infarctions [Phase 2]
Phase 2 trial evaluating bone marrow-derived stem cell transfer in patients with acute myocardial infarction has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure [Phase 2, Phase 3]
This clinical trial update reports completion of Phase 2/3 testing of bypass surgery with CD133-positive marrow cell injections for ischemic…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Efficacy of Combination of IntraCoronary Bolus Abciximab and Aspiration Thrombectomy in STEMI [Phase 4]
Phase 4 trial update evaluating the efficacy of combining intracoronary bolus abciximab with aspiration thrombectomy in patients with STEMI.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Intracoronary Abciximab With Clearway Catheter [Phase 3]
A Phase 3 study of intracoronary abciximab with the Clearway catheter for acute myocardial infarction has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: Anti-inflammatory Effects of Intracoronary and Intravenous Abciximab Administration During Primary Percutaneous Coronary Intervention [Phase 4]
A Phase 4 clinical trial evaluated anti-inflammatory effects of intracoronary and intravenous abciximab administration during primary percut…
-
CLINICAL_TRIALS research · 2012-12-31Clinical Trial Update: inflAmmatory maRkers in Blood and Thrombus Aspirated From Patients With acutE myocaRdial Infarction With St-segment elevAtion
Clinical trial update examining inflammatory markers in blood and thrombus aspirate from patients with ST-elevation myocardial infarction.
-
CLINICAL_TRIALS research · 2012-12-27Clinical Trial Update: IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting
This is a completed registry study (IMPROVE HF) evaluating the use of evidence-based heart failure therapies in outpatient settings, with re…
-
CLINICAL_TRIALS trial_result · 2012-12-27Clinical Trial Update: Bone Marrow Derived AC 133+ and Mono-Nuclear Cells (MNC) Implantation in Myocardial Infarction (MI) Patient [Phase 2, Phase 3]
Status update indicating completion of Phase 2/3 clinical trials evaluating implantation of bone marrow–derived AC133+ (CD133+) and mono-nuc…
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED) [Phase 3]
A Phase 3 trial evaluating acadesine for reducing cardiovascular and cerebrovascular adverse events in patients undergoing coronary artery b…
-
FDA approval · 2012-12-17FDA Approved: QUINAPRIL — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for Quinapril from Cipla USA Inc., marking an additional regulatory action for this ACE inhibito…
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: The Long-term and Short-term Efficacy and Safety of Transplantation Autologous Bone Marrow Cells (BMCs) in Patients With the First STEMI (ST Segment Elevation Myocardial Infarction) [Phase 2]
Phase 2 trial update describing the long-term and short-term efficacy and safety of autologous bone marrow cell transplantation in patients …
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Validation of a High-risk Versus Low-risk Referral Model in Suspected Acute Coronary Syndrome
This clinical trial update reports validation of a high-risk versus low-risk referral model for patients with suspected acute coronary syndr…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Risk of Life-threatening Heart Rhythm Disturbances in Siblings
A completed clinical trial update discusses sibling risk for life-threatening heart rhythm disturbances in the context of implantable defibr…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Randomized Study to Assess the Effect of ThRombus Aspiration on Flow Area in STEMI Patients [Phase 1, Phase 2]
A randomized study (Phase 1 and Phase 2) evaluating the effect of ThRombus aspiration on flow area in STEMI patients, sponsored by Terumo Eu…
-
FDA approval · 2012-12-05FDA Approved: BRILINTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Brilinta (ticagrelor) from AstraZeneca Pharmaceuticals LP. This action approves changes to Brili…
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: Effect of N-acetylcystein in Myocardial Infarction [Phase 3]
This document provides a Phase 3 clinical trial update on N-acetylcysteine for acute myocardial infarction, with the current trial status un…
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition [Phase 1]
Completed Phase 1 bioequivalence study of Lisinopril 40 mg tablets under fed conditions conducted by IPCA Laboratories Ltd.
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Heart Disease Death
A completed clinical trial investigated whether low-dose acetylsalicylic acid (aspirin) use with proton pump inhibitors is associated with t…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Death
A completed clinical trial evaluated whether concurrent use of low-dose aspirin and a proton pump inhibitor affects the risk of acute myocar…
-
CLINICAL_TRIALS research · 2012-11-14Clinical Trial Update: Readiness for Behavior Change After a Heart Attack [NA]
A completed clinical trial from Henry Ford Health System evaluating readiness for behavior change after a heart attack.
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: SWiss Multicenter Intracoronary Stem Cells Study in Acute Myocardial Infarction (SWISS-AMI) [Phase 2]
Phase 2 SWISS-AMI trial evaluating intracoronary stem cell therapy for acute myocardial infarction has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: Effects of Postconditioning On Myocardial Reperfusion [NA]
A completed clinical trial evaluating the effects of postconditioning on myocardial reperfusion in patients with myocardial infarction.
-
FDA label_change · 2012-10-31FDA Approved: ZESTRIL — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for Zestril (lisinopril) from Upsher-Smith Laboratories, resulting in updated labeling.